Lignan Research Inc. Report issue

For profit Phase 2
Founded: San Diego CA United States (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2010
NCT01276704
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

secoisolariciresinol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1